Following the Reuters Events Pharma USA 2024, PharmaShots brings an engaging conversation with Moreno Perugini, President, of Néstle Health Science. Moreno begins the conversation by highlighting Néstle’s journey to become a full-fledged pharma company through a series of acquisitions and deals.
Moreno recalls Néstle’s transitioning into a pharmaceutical company when the company got the rights for Zenpep,…
Shots:
The US FDA approved 6 NDAs and 4 BLA in April 2023, leading to treatments for patients and advances in the healthcare industry. The CDER and CBER approved 36 novel products in 2023
In April 2023, the major highlights drugs were, Trikafta approval for children with cystic fibrosis, Qalsody for the treatment of amyotrophic…

